Interestingly, one study has shown that 63.3% of breast cancers are positive for IFNα and that stage III breast cancers had no IFNα binding to the receptor complex suggesting constitutive secretion of IFNα but a lack of autocrine signaling [43]. This evidence concerns the gene IFNA1 and breast cancer.